Refine
Has Fulltext
- yes (39) (remove)
Is part of the Bibliography
- yes (39) (remove)
Document Type
- Journal article (30)
- Doctoral Thesis (9)
Keywords
- SARS-CoV-2 (39) (remove)
Institute
- Institut für Virologie und Immunbiologie (11)
- Theodor-Boveri-Institut für Biowissenschaften (9)
- Institut für Organische Chemie (7)
- Klinik und Poliklinik für Anästhesiologie (ab 2004) (6)
- Medizinische Klinik und Poliklinik II (4)
- Institut für Hygiene und Mikrobiologie (3)
- Institut für Molekulare Infektionsbiologie (3)
- Kinderklinik und Poliklinik (3)
- Graduate School of Life Sciences (2)
- Institut für Klinische Epidemiologie und Biometrie (2)
Sonstige beteiligte Institutionen
EU-Project number / Contract (GA) number
- 101007642 (1)
Acetylsalicylic acid and salicylic acid inhibit SARS-CoV-2 replication in precision-cut lung slices
(2022)
Aspirin, with its active compound acetylsalicylic acid (ASA), shows antiviral activity against rhino- and influenza viruses at high concentrations. We sought to investigate whether ASA and its metabolite salicylic acid (SA) inhibit SARS-CoV-2 since it might use similar pathways to influenza viruses. The compound-treated cells were infected with SARS-CoV-2. Viral replication was analysed by RTqPCR. The compounds suppressed SARS-CoV-2 replication in cell culture cells and a patient-near replication system using human precision-cut lung slices by two orders of magnitude. While the compounds did not interfere with viral entry, it led to lower viral RNA expression after 24 h, indicating that post-entry pathways were inhibited by the compounds.